|
1
|
Heit JA: The epidemiology of venous
thromboembolism in the community. Arterioscler Thromb Vasc Biol.
28:370–372. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang L, Song H, Gong Z, Duan Q and Liang
A: Acute pulmonary embolism and dysfunction of CD3+ CD8+ T cell
immunity. Am J Respir Crit Care Med. 184:13152011.PubMed/NCBI
|
|
3
|
Haoming S, Lemin W, Zhu G, et al: T
cell-mediated immune deficiency or compromise in patients with
CTEPH. Am J Respir Crit Care Med. 183:417–418. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sang Y, Rowland RR, Hesse RA and Blecha F:
Differential expression and activity of the porcine type I
interferon family. Physiol Genomics. 42:248–258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Day SL, Ramshaw IA, Ramsay AJ and
Ranasinghe C: Differential effects of the type I interferons
alpha4, beta, and epsilon on antiviral activity and vaccine
efficacy. J Immunol. 180:7158–7166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abbas AK and Lichtman AH: Cellular and
Molecular Immunology. 5th edition. Saunders; Philadelphia, PA: 562.
2005
|
|
7
|
Bray M: The role of the Type I interferon
response in the resistance of mice to filovirus infection. J Gen
Virol. 82:1365–1373. 2001.PubMed/NCBI
|
|
8
|
van den Broek MF, Müller U, Huang S,
Zinkernagel RM and Aguet M: Immune defence in mice lacking type I
and/or type II interferon receptors. Immunol Rev. 148:5–18.
1995.PubMed/NCBI
|
|
9
|
Font A and Closa JM: Ultrasonographic
localization of a caudal vena cava thrombus in a dog with
leishmaniasis. Vet Radiol Ultrasound. 38:394–396. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Komazaki Y, Sakakibara Y, Sakashita H,
Miyazaki Y and Inase N: Pulmonary thromboembolism with pulmonary
tuberculosis. Kekkaku. 86:717–722. 2011.(In Japanese).
|
|
11
|
Constant SL and Bottomly K: Induction of
Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu
Rev Immunol. 15:297–322. 1997.
|
|
12
|
Romagnani S: Biology of human TH1 and TH2
cells. J Clin Immunol. 15:121–129. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kidd P: Th1/Th2 balance: the hypothesis,
its limitations, and implications for health and disease. Altern
Med Rev. 8:223–246. 2003.PubMed/NCBI
|
|
14
|
LoPresti R, Ferrara F, Canino B, Montana M
and Caimi G: Deep venous thrombosis: leukocyte rheology at baseline
and after in vitro activation. Haemostasis. 30:168–173.
2000.PubMed/NCBI
|
|
15
|
Esposito CJ, Popescu WM, Rinder HM,
Schwartz JJ, Smith BR and Rinder CS: Increased leukocyte-platelet
adhesion in patients with graft occlusion after peripheral vascular
surgery. Thromb Haemost. 90:1128–1134. 2003.PubMed/NCBI
|
|
16
|
Cocchi F, DeVico AL, Garzino-Demo A, Arya
SK, Gallo RC and Lusso P: Identification of RANTES, MIP-1 alpha,
and MIP-1 beta as the major HIV-suppressive factors produced by
CD8+ T cells. Science. 270:1811–1815. 1995.
|
|
17
|
Crawford A, Angelosanto JM, Nadwodny KL,
Blackburn SD and Wherry EJ: A role for the chemokine RANTES in
regulating CD8 T cell responses during chronic viral infection.
PLoS Pathog. 7:e10020982011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Domachowske JB, Bonville CA, Gao JL,
Murphy PM, Easton AJ and Rosenberg HF: The chemokine
macrophage-inflammatory protein-1 alpha and its receptor CCR1
control pulmonary inflammation and antiviral host defense in
paramyxovirus infection. J Immunol. 165:2677–2682. 2000. View Article : Google Scholar
|
|
19
|
Trifilo MJ, Bergmann CC, Kuziel WA and
Lane TE: CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell
effector function and migration following viral infection. J Virol.
77:4004–4014. 2003.
|
|
20
|
Vinay DS and Kwon BS: Immunotherapy
targeting 4-1BB and its ligand. Int J Hematol. 83:23–28. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li CH, Xu KL, Pan XY and Du B: Study on
control of graft-versus-host disease by blocking CD137-CD137L
ligand costimulatory pathway in mice. Zhonghua Xue Ye Xue Za Zhi.
28:93–97. 2007.(In Chinese).
|
|
22
|
Lee SC, Ju SA, Pack HN, et al: 4-1BB
(CD137) is required for rapid clearance of Listeria monocytogenes
infection. Infect Immun. 73:5144–5151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
DeBenedette MA, Wen T, Bachmann MF, et al:
Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice
lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin
allograft rejection and in the cytotoxic T cell response to
influenza virus. J Immunol. 163:4833–4841. 1999.PubMed/NCBI
|
|
24
|
Herbein G and O’Brien WA: Tumor necrosis
factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc
Soc Exp Biol Med. 223:241–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Micheau O and Tschopp J: Induction of TNF
receptor I-mediated apoptosis via two sequential signaling
complexes. Cell. 114:181–190. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
de Oliveira Pinto LM, Garcia S, Lecoeur H,
Rapp C and Gougeon ML: Increased sensitivity of T lymphocytes to
tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated
apoptosis in HIV infection: relation to expression of Bcl-2 and
active caspase-8 and caspase-3. Blood. 99:1666–1675.
2002.PubMed/NCBI
|
|
27
|
Gonzalez-Juarrero M, Hattle JM, Izzo A, et
al: Disruption of granulocyte macrophage-colony stimulating factor
production in the lungs severely affects the ability of mice to
control Mycobacterium tuberculosis infection. J Leukoc Biol.
77:914–922. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wan J, Lu LJ, Miao R, et al: Alterations
of bone marrow-derived endothelial progenitor cells following acute
pulmonary embolism in mice. Exp Biol Med (Maywood). 235:989–998.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Govinden R and Bhoola KD: Genealogy,
expression, and cellular function of transforming growth
factor-beta. Pharmacol Ther. 98:257–265. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li MO, Wan YY, Sanjabi S, Robertson AK and
Flavell RA: Transforming growth factor-beta regulation of immune
responses. Annu Rev Immunol. 24:99–146. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Haagmans BL, Teerds KJ, van den
Eijnden-van Raaij AJ, Horzinek MC and Schijns VE: Transforming
growth factor beta production during rat cytomegalovirus infection.
J Gen Virol. 78(Pt 1): 205–213. 1997.PubMed/NCBI
|
|
32
|
Yoo YD, Ueda H, Park K, et al: Regulation
of transforming growth factor-beta 1 expression by the hepatitis B
virus (HBV) X transactivator. Role in HBV pathogenesis. J Clin
Invest. 97:388–395. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kekow J, Wachsman W, McCutchan JA, et al:
Transforming growth factor-beta and suppression of humoral immune
responses in HIV infection. J Clin Invest. 87:1010–1016. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gong Z, Liang AB, Wang LM, et al: The
expression and significance of immunity associated genes mRNA in
patients with pulmonary embolism. Zhonghua Nei Ke Za Zhi.
48:666–669. 2009.(In Chinese).
|
